193 related articles for article (PubMed ID: 18276786)
1. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid.
Gérard AC; Poncin S; Caetano B; Sonveaux P; Audinot JN; Feron O; Colin IM; Soncin F
Am J Pathol; 2008 Mar; 172(3):748-60. PubMed ID: 18276786
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
3. Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes.
Gérard AC; Poncin S; Audinot JN; Denef JF; Colin IM
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1414-22. PubMed ID: 19336661
[TBL] [Abstract][Full Text] [Related]
4. Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors.
Craps J; Wilvers C; Joris V; De Jongh B; Vanderstraeten J; Lobysheva I; Balligand JL; Sonveaux P; Gilon P; Many MC; Gérard AC; Colin IM
Endocrinology; 2015 Feb; 156(2):707-20. PubMed ID: 25406019
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter.
Ock S; Ahn J; Lee SH; Kang H; Offermanns S; Ahn HY; Jo YS; Shong M; Cho BY; Jo D; Abel ED; Lee TJ; Park WJ; Lee IK; Kim J
FASEB J; 2013 Dec; 27(12):4899-908. PubMed ID: 23982142
[TBL] [Abstract][Full Text] [Related]
6. Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling.
Ramsden JD; Buchanan MA; Egginton S; Watkinson JC; Mautner V; Eggo MC
Endocrinology; 2005 Jul; 146(7):2895-902. PubMed ID: 15817662
[TBL] [Abstract][Full Text] [Related]
7. Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function.
Wang JF; Milosveski V; Schramek C; Fong GH; Becks GP; Hill DJ
J Endocrinol; 1998 Apr; 157(1):5-12. PubMed ID: 9614352
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.
Craps J; Joris V; De Jongh B; Sonveaux P; Horman S; Lengelé B; Bertrand L; Many MC; Colin IM; Gérard AC
Endocrinology; 2016 Jun; 157(6):2545-59. PubMed ID: 27035650
[TBL] [Abstract][Full Text] [Related]
9. Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors.
Yamada E; Yamazaki K; Takano K; Obara T; Sato K
Thyroid; 2006 Jun; 16(6):545-54. PubMed ID: 16839256
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical profile of angiogenesis in the thyroid gland in various thyroid diseases].
Rurua NZ; Gogiashvili LE; Tsagareli ZG
Georgian Med News; 2013 Dec; (225):97-104. PubMed ID: 24423685
[TBL] [Abstract][Full Text] [Related]
11. Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway.
Gérard AC; Humblet K; Wilvers C; Poncin S; Derradji H; de Ville de Goyet C; Abou-el-Ardat K; Baatout S; Sonveaux P; Denef JF; Colin IM
Thyroid; 2012 Jul; 22(7):699-708. PubMed ID: 22663304
[TBL] [Abstract][Full Text] [Related]
12. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
[TBL] [Abstract][Full Text] [Related]
13. Effect of the micronutrient iodine in thyroid carcinoma angiogenesis.
Daniell K; Nucera C
Aging (Albany NY); 2016 Dec; 8(12):3180-3184. PubMed ID: 27997357
[TBL] [Abstract][Full Text] [Related]
14. [Etiopathogenesis and therapy of iodine deficiency goiter].
Gärtner R
Z Arztl Fortbild (Jena); 1995 Feb; 89(1):27-31. PubMed ID: 7709641
[TBL] [Abstract][Full Text] [Related]
15. Recent insights into the cell biology of thyroid angiofollicular units.
Colin IM; Denef JF; Lengelé B; Many MC; Gérard AC
Endocr Rev; 2013 Apr; 34(2):209-38. PubMed ID: 23349248
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth.
Song YS; Kim MJ; Sun HJ; Kim HH; Shin HS; Kim YA; Oh BC; Cho SW; Park YJ
Clin Cancer Res; 2019 Jan; 25(1):414-425. PubMed ID: 30314969
[TBL] [Abstract][Full Text] [Related]
18. Biphasic modulation of insulin receptor substrate-1 during goitrogenesis.
Grozovsky R; Morales MM; Carvalho DP
Braz J Med Biol Res; 2007 May; 40(5):679-86. PubMed ID: 17464430
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin.
Bray GA
J Clin Invest; 1968 Jul; 47(7):1640-7. PubMed ID: 4298076
[TBL] [Abstract][Full Text] [Related]
20. Biochemistry of thyroid regulation under normal and abnormal conditions.
Pisarev MA; Kleiman de Pisarev DL
J Endocrinol Invest; 1980; 3(3):317-29. PubMed ID: 6253558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
